Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study

Affiliations

• ¹ Cytokinetics, Incorporated, South San Francisco, CA, USA.
• ² Columbia University, New York, NY, USA.
• ³ Stanford University, Stanford, CA, USA.
• ⁴ Sangamo Therapeutics, Brisbane, CA, USA.
• ⁵ Montreal Neurological Institute, Montreal, QC, Canada.
• ⁶ Virginia Commonwealth University, Richmond, VA, USA.
• ⁷ University of Utah, Salt Lake City, UT, USA.
• ⁸ Nationwide Children's Hospital, Columbus, OH, USA.
• ⁹ Washington University, St Louis, MO, USA.
• ¹⁰ Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
• ¹¹ Hospital for Special Care, New Britain, CT, USA.
• ¹² Nemours Children's Hospital, Orlando, FL, USA.
• ¹³ St. Jude Children's Research Hospital, Memphis, TN, USA.
• ¹⁴ University of California, Los Angeles, Los Angeles, CA, USA.
• ¹⁵ University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada.
• ¹⁶ University of Kansas, Lawrence, KS, USA.
• ¹⁷ Department of Pediatrics, Epidemiology and Clinical Neurological Sciences, University of Western Ontario, London Health Sciences Centre, London, ON, Canada.
• ¹⁸ University of California, Irvine, Orange, CA, USA.
• ¹⁹ Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
• ²⁰ McGill University Health Centre Research Institute, Montreal, QC, Canada.
• ²¹ Stanford University, Stanford, CA, USA. jwday@stanford.edu.